The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Diagnosis Can Be Elusive for Fever of Unknown Origin

Diagnosis Can Be Elusive for Fever of Unknown Origin

March 15, 2016 • By Charles Radis, DO

  • Tweet
  • Email
Print-Friendly Version / Save PDF

I thought back to the first day of an elective surgical rotation when I was a fourth-year medical student. The surgeon at the small southern community hospital brusquely shook my hand and said, “Internal medicine? You’re going into internal medicine instead of surgery?”

You Might Also Like
  • Opinion: More Tests Needed to Diagnose Fever of Unknown Origin
  • Inflammatory Origin of Fever Is Key to Diagnosis
  • Diagnosis, Treatment for Patient with Psoriasis, Fever, Bloating, and Rash
Explore This Issue
March 2016
Also By This Author
  • Diffuse Scleroderma: A 1991 Case Through the Lens of Today

“Yes,” I said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“You’re going to be a flea,” he drawled.

“A flea?”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“That’s right, a flea. The first to jump onto a patient and the last to get off.”

“Well,” I stammered, “that’s a good thing, isn’t it?” In internal medicine and in the practice of rheumatology, sometimes the answers don’t come easily. You’ve got to dig.

Second Opinion

Although her joint and muscle pain were only marginally improved with daily meloxicam, Mrs. N stoically refused a trial of prednisone. I sent her south for a second opinion at the Lahey Clinic in Boston. She wanted answers.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The Lahey Clinic rheumatologist suggested that Mrs. N was suffering from adult-onset Still’s disease, a rare, systemic subset of childhood arthritis that has been described in adults.

I’d considered Still’s during Mrs. N’s first hospitalization, but didn’t feel she fit the criteria for the diagnosis. Again, like so many disorders in rheumatology, there is no single conclusive test to confirm adult-onset Still’s disease. The daily fevers and intense muscle and joint pain certainly fit the bill, as did the dramatically elevated inflammatory markers—the sedimentation rate and C-reactive protein. But patients with Still’s disease also demonstrate an evanescent salmon-colored rash with the daily fevers, which Mrs. N lacked. My mind was open to the possibility of Still’s, but without the rash (the rash is so singular, it’s called a Still’s rash), we both agreed this was only one possibility among many.

Medication Trials

Mrs. N acquiesced to a trial of weekly injectable methotrexate, but was, at most, 10–20% better after eight weeks, and she discontinued the drug on her own. The sedimentation rate and C-reactive protein levels redlined as if she were taking nothing whatsoever.

Without a specific diagnosis, Mrs. N wanted to hold off on prednisone. I argued—once again—that we could easily manage elevated blood sugars if they spiked on prednisone and further, there were medications to maintain or improve bone strength if prednisone was necessary long term.

Her reply: “So you’re going to give me prednisone and two other medications for a disease you can’t name, for a duration you can’t guess, with side effects worse than the disease.”

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 | Single Page

Filed Under: Conditions Tagged With: Diagnosis, fever, origin, patient care, prodrome, Rheumatic Disease, Rheumatoid arthritis, rheumatologist, Sarcoidosis, unknownIssue: March 2016

You Might Also Like:
  • Opinion: More Tests Needed to Diagnose Fever of Unknown Origin
  • Inflammatory Origin of Fever Is Key to Diagnosis
  • Diagnosis, Treatment for Patient with Psoriasis, Fever, Bloating, and Rash
  • Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.